About: The opening salvo of anti-complement therapy against COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The opening salvo of anti-complement therapy against COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 September 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en setiembre de 2020 (ast) наукова стаття, опублікована 28 вересня 2020 (uk) scientific article published on 28 September 2020 (en)
publication date	wds:Q100440359-15256F86-99CB-45A5-AB4B-026A3402329D
publication date	2020-09-28 00:00:00Z (xsd:dateTime)
cites work	wds:Q100440359-1FDB3D00-D541-409E-B92D-C31008E4512E wds:Q100440359-25CDF959-01AB-4F80-B800-37466340560D wds:Q100440359-480FABF4-24DA-445B-9037-CED3A11A2A28 wds:Q100440359-60D80252-75B1-41B4-BD81-0263E5F68314 wds:Q100440359-7C2D7F1F-7E8C-43F9-8F5C-488E12C8A0A8 wds:Q100440359-9B771E93-7633-44CB-8A0F-64B394E65BA8 wds:Q100440359-ED166946-D787-46E4-B9B4-C61F668373EF wds:Q100440359-FEBB6CE7-097F-4759-9B74-0834324E3021
cites work	COMPLEMENT ACTIVATION IN PATIENTS WITH COVID-19: A NOVEL THERAPEUTIC TARGET Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases Proteomic and Metabolomic Characterization of COVID-19 Patient Sera Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19 Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
author name string	wds:Q100440359-9D55B2DF-94D6-49DE-99E6-AD11A902C773
author name string	Courtney M Campbell
rdfs:label	The opening salvo of anti-complement therapy against COVID-19 (en) The opening salvo of anti-complement therapy against COVID-19 (nl)
skos:prefLabel	The opening salvo of anti-complement therapy against COVID-19 (en) The opening salvo of anti-complement therapy against COVID-19 (nl)
name	The opening salvo of anti-complement therapy against COVID-19 (en) The opening salvo of anti-complement therapy against COVID-19 (nl)
title	wds:Q100440359-C2B4C29A-EEA0-411A-8462-FC53436B1997
title	The opening salvo of anti-complement therapy against COVID-19 (en)
instance of	wds:Q100440359-52AAD048-59AE-49F4-82C1-67AFA9AB5B52
instance of	scholarly article
main subject	wds:Q100440359-800AAF37-67E6-4328-B972-8E2CEAAFE45A
main subject	COVID-19 mortality
PubMed ID	wds:Q100440359-5E6D9191-114D-40D8-BCE8-3082BF164104
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33015642
PubMed ID	33015642
published in	wds:Q100440359-2ADA6397-F529-48EA-9093-7A964B02DB67
published in	The Lancet Rheumatology
DOI	wds:Q100440359-AD1BA0E4-21BE-4B9B-A485-BC3926469699
DOI	http://dx.doi.org/10.1016/S2665-9913(20)30353-2
DOI	10.1016/S2665-9913(20)30353-2
PMCID	wds:Q100440359-C600CBAC-C88C-4DD7-A80D-5998C7893611
PMCID	7521911
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q100440359

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software